Artivion, Inc. (AORT) earnings
AORT earnings moved a median of +0.40% by the close. Quarterly and annual AORT reports and results, each read against the price at its own news timestamp. Back to the AORT overview →
31 measured AORT earnings events.
Where these AORT earnings landedvs 31 measured AORT earnings reactions
| Middle 50% of AORT earnings reactions | -1.34% to +1.44% |
|---|---|
| Median reaction (to close) | +0.40% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 AORT earnings events with a measured close landed between -1.34% and +1.44%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ARTIVION, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.36% | -2.53% | |
| Artivion Reports Third Quarter 2026 Financial Results | Press release | -1.49% | -8.92% | |
| Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results | Press release | +0.46% | -2.35% | |
| Form 10-Q ARTIVION, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.01% | -1.45% | |
| Artivion Reports Second Quarter 2026 Financial Results | Press release | +1.57% | -0.95% | |
| Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results | Press release | -0.67% | +0.12% | |
| Form 10-Q ARTIVION, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.20% | +0.40% | |
| Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan | Press release | -13.67% | +3.71% | |
| Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results | Press release | -0.65% | +2.03% | |
| Form 10-K ARTIVION, INC. For: Dec 31 | SEC filing · Form 10-K | +0.40% | +1.23% | |
| Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results | Press release | +0.30% | +0.59% | |
| Form 10-Q ARTIVION, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.85% | -2.16% | |
| Artivion Reports Third Quarter 2025 Financial Results | Press release | +1.01% | -3.77% | |
| Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results | Press release | -0.39% | -0.55% | |
| Form 10-Q ARTIVION, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.18% | +4.79% | |
| Artivion Reports Second Quarter 2025 Financial Results | Press release | +2.36% | +6.39% | |
| Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results | Press release | -0.38% | +0.45% | |
| Form 10-Q ARTIVION, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.04% | +0.37% | |
| Artivion Reports First Quarter 2025 Financial Results | Press release | +1.00% | +9.86% | |
| Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results | Press release | +0.22% | +1.75% | |
| Form 10-K ARTIVION, INC. For: Dec 31 | SEC filing · Form 10-K | +0.22% | +0.35% | |
| Form 10-Q ARTIVION, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.25% | +0.95% | |
| Artivion Reports Third Quarter 2024 Financial Results | Press release | -5.05% | -2.68% | |
| Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results | Press release | +0.00% | -0.64% | |
| Form 10-Q ARTIVION, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.20% | +0.93% | |
| Artivion Reports Second Quarter 2024 Financial Results | Press release | +1.20% | -4.20% | |
| Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results | Press release | +0.00% | -1.22% | |
| Form 10-Q ARTIVION, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.55% | +0.59% | |
| Artivion Reports First Quarter 2024 Financial Results | Press release | +7.69% | +3.80% | |
| Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results | Press release | +0.00% | +1.66% | |
| Form 10-K ARTIVION, INC. For: Dec 31 | SEC filing · Form 10-K | +1.00% | +0.60% |
Keep exploring
More AORT: analyst actions → · SEC filings → · AORT overview →